Narasimham L. Parinandi

This researcher studies how oxidative stress, reactive oxygen species, and lipid-derived molecules affect blood vessel and lung cell function, with implications for diseases such as pulmonary fibrosis, atherosclerosis, and lung injury caused by pathogens or environmental toxins like ozone. Recent work has expanded into computational and network-pharmacology approaches to study drug design for conditions including malaria, cancer, and osteoporosis. The lab combines cell biology, biochemistry, and increasingly computational modeling to understand disease mechanisms and potential therapeutic targets.

Publication output has fluctuated over the past decade with a notable peak in 2020, a dip afterward, and a resurgence in 2025, averaging about 5 publications per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026